Drug Combination Shrinks Breast Cancer Metastases In Brain
Lapatinib (Tykerb) and capecitabine (Xeloda) were paired in an extension of a Phase 2 clinical trial in which lapatinib given alone shrank brain metastases significantly in six percent of 241 patients
To read full article: http://www.sciencedaily.com/releases...1216104315.htm |
All times are GMT -7. The time now is 03:27 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021